San Francisco, CA, United States of America

Andrew W Waltman

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 11.4

ph-index = 3

Forward Citations = 86(Granted Patents)


Location History:

  • Kalamazoo, MI (US) (2021)
  • San Francisco, CA (US) (2016 - 2022)

Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: **Innovations and Contributions of Andrew W Waltman in Pharmaceutical Chemistry**

Introduction

Andrew W Waltman, an accomplished inventor based in San Francisco, CA, has made significant strides in the field of pharmaceutical chemistry. With a portfolio of seven patents, Waltman has focused his research and innovations on combatting viral infections, particularly those caused by the Filoviridae family, including Ebola and Marburg viruses.

Latest Patents

Waltman’s latest patents showcase his expertise in developing methods for the preparation of ribosides. One notable patent outlines methods for synthesizing a compound designated as Formula VIII, which aims to treat Filoviridae virus infections. This innovation employs a complex reaction mixture that includes a coupling agent like magnesium chloride and a non-nucleophilic base, diisopropylethylamine, to achieve the desired compound. Moreover, his work also includes processes for creating 1'-substituted carba-nucleoside analogs, integral for synthesizing nucleosides of various heterocycles, crucial in advancing therapeutic options against severe viral infections.

Career Highlights

Throughout his career, Andrew W Waltman has contributed to significant advancements in pharmaceutical research while working with prestigious organizations, including Gilead Sciences, Inc. and Gilead Pharmasset LLC. His work in these companies has not only influenced the development of important antiviral compounds but also fostered a collaborative environment for innovation in drug development.

Collaborations

Waltman’s contributions are further enhanced through collaborations with esteemed colleagues such as Bruce Ross and Dustin S Siegel. These partnerships have facilitated a robust exchange of ideas and techniques, ensuring that their collective research remains at the forefront of addressing critical health challenges related to viral infections.

Conclusion

In summary, Andrew W Waltman exemplifies the role of an innovative inventor within the pharmaceutical sector. His groundbreaking patents and collaborative efforts underscore his commitment to advancing medical science, particularly in the fight against viral infections. As his work continues to unfold, the impact of Waltman's research will undoubtedly contribute to the development of effective treatments and therapies that enhance public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…